Related Experiment Video
Updated: Sep 22, 2025

07:34
A Cost-effective and Reliable Method to Predict Mechanical Stress in Single-use and Standard Pumps
Published on: August 5, 2015
9.6K
Accuracy Evaluation of a Novel Reusable Patch Pump Prototype
Jochen Mende1, Annette Baumstark1, Delia Waldenmaier1
1Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany.
Journal of Diabetes Science and Technology
|May 21, 2022
Summary
A new insulin patch pump prototype with a double pump mechanism demonstrated high accuracy in delivering both bolus and basal insulin doses. It also features rapid occlusion detection, performing comparably to existing commercial insulin pumps.
Area of Science:
- Biomedical Engineering
- Medical Devices
- Diabetes Technology
Background:
- Insulin patch pumps are crucial for diabetes management, offering discreet and automated insulin delivery.
- Ensuring accurate insulin delivery and reliable safety features like occlusion detection is paramount for patient safety and glycemic control.
- Existing commercial insulin pumps vary in their performance regarding accuracy and safety mechanisms.
Purpose of the Study:
- To evaluate the accuracy of bolus and basal insulin delivery from a novel insulin patch pump prototype.
- To assess the effectiveness and speed of the prototype's occlusion detection system.
- To compare the performance of the prototype against established commercial insulin pumps.
Main Methods:
- A microgravimetric method was employed to precisely measure insulin delivery accuracy for bolus doses (0.2 U, 1.0 U) and basal rates (1.0 U/h).
- Occlusion detection time was assessed at two different basal rates (0.1 U/h and 1.0 U/h).
- Performance metrics were compared with data from commercially available insulin pumps tested using similar methodologies.
Main Results:
- The prototype exhibited high accuracy, with mean deviations below 2% for both 0.2 U and 1.0 U bolus deliveries.
- Basal rate accuracy over 72 hours showed a mean deviation of less than 1%.
- Occlusion detection was achieved in under 30 minutes at both tested basal rates.
Conclusions:
- The tested insulin patch pump prototype demonstrates excellent accuracy in insulin delivery, meeting or exceeding the performance of many commercial devices.
- The prototype's occlusion detection system is effective and operates within clinically relevant timeframes.
- These findings suggest the prototype holds significant promise as a reliable and safe alternative for insulin therapy in diabetes management.

